- Ticker
- AKTX
- Price
- 1.40
- Stock movement down
- -0.01 (-0.71%)
- Company name
- Akari Therapeutics PLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 5.21M
- Ent value
- 105.58K
- Price/Sales
- -
- Price/Book
- 0.63
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -65.00%
- 3 year return
- -70.44%
- 5 year return
- -52.87%
- 10 year return
- -
Last updated: 2024-04-08
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
AKTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.63 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.72M |
| EPS (TTM) | -6.10 |
| FCF per share (TTM) | -5.12 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -18.40M |
| Net income (TTM) | -18.10M |
| EPS (TTM) | -6.10 |
| EPS (1y forward) | -6.00 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 8.15M |
| Net receivables | 0.00 |
| Total current assets | 11.35M |
| Goodwill | 0.00 |
| Intangible assets | 18.84K |
| Property, plant and equipment | 0.00 |
| Total assets | 11.37M |
| Accounts payable | 1.63M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.05M |
| Total liabilities | 3.05M |
| Shareholder's equity | 8.33M |
| Net tangible assets | 8.31M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -20.19M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -15.18M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -217.35% |
| Return on Assets | -159.14% |
| Return on Invested Capital | -217.35% |
| Cash Return on Invested Capital | -182.35% |
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
September 5, 2023
iO Charts is a Seeking Alpha partner
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
August 15, 2023
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.42 |
| Daily high | 1.50 |
| Daily low | 1.20 |
| Daily Volume | 5K |
| All-time high | 5000.00 |
| 1y analyst estimate | 55.00 |
| Beta | 1.39 |
| EPS (TTM) | -6.10 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 29 Apr 2024 |
Downside potential
Loading...
Downside potential data
| AKTX | S&P500 | |
| Current price drop from All-time high | -99.97% | -0.85% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 8 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -95.82% | -11.35% |
| Avg time to new high | 2517 days | 13 days |
| Max time to new high | 2516 days | 1805 days |
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
May 1, 2023
iO Charts is a Seeking Alpha partner
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
March 30, 2023
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
5.21M
Marketcap category
Small-cap
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.
Employees
9
Website
Investor relations
-
SEC filings
CEO
Clive Stuart Richardson
Country
USA
City
London
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
October 28, 2022
iO Charts is a Seeking Alpha partner
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
September 27, 2022
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
September 12, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
August 1, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
July 28, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
July 20, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
July 7, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
June 13, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
May 16, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
March 8, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
March 2, 2022
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
January 26, 2022
iO Charts is a Seeking Alpha partnerNext page